Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7074782
Carbamate caspase inhibitors and uses thereof
granted patentUS 7067661
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted patentUS 7060733
Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxyge
granted patentUS 7056944
Pyrazole compositions useful as inhibitors of erk
granted patentUS 7053119
Methods for identifying and using IKK inhibitors
granted patentUS 7053057
Caspase inhibitors and uses thereof
granted patentUS 7041687
Indazole compounds useful as protein kinase inhibitors
expired patentUS 7037912
Protein kinase inhibitors
expired patentUS 7015212
Thiazepine inhibitors of HIV-1 integrase
expired patentUS 7008948
Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6994868
Compositions useful as inhibitors of ERK
expired patentUS 6995261
4-pyridazinecarboxamides and esters as interleukin-1Ξ² converting enzyme inhibitors
expired patentUS 6995141
Interleukin 1Ξ² protease and interleukin 1Ξ² protease inhibitors
expired patentUS 6989385
Pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6977241
SH2 domain binding inhibitors
expired patentUS 6974809
Inhibitors of interleukin 1-Ξ² converting enzyme
expired patentUS 6974806
Lipid-rich plaque inhibitors
expired patentUS 6967214
Inhibitors of IMPDH enzyme
expired patentUS 6962996
Inhibitors of p38
expired patentUS 6962936
Triazole-derived kinase inhibitors and uses thereof
expired patentUS 6953786
Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive ox
expired patentUS 6951915
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target
expired patentUS 6949580
Pyrazole compositions useful as inhibitors of ERK
expired patentUS 6949544
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
expired